Fir Tree Capital Management LP Abb Vie Inc. Transaction History

Fir Tree Capital Management LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$107.43 - $135.93 $57.6 Million - $72.8 Million	-535,788 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$106.4 - $120.78 $5.91 Million - $6.71 Million	-55,571 Reduced 9.4%	535,788 $57.8 Million
Q2 2021 Aug 16, 2021	SELL	$105.21 - $117.21 $4.98 Million - $5.55 Million	-47,321 Reduced 7.41%	591,359 $66.6 Million
Q1 2021 May 17, 2021	BUY	$102.3 - $112.62 $1.07 Million - $1.18 Million	10,451 Added 1.66%	638,680 $69.1 Million
Q4 2020 Feb 16, 2021	BUY	$80.49 - $108.67 $50.6 Million - $68.3 Million	628,229 New	628,229 $67.3 Million

3,853

1.25B

16.8M

12.2M

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $318B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

Get notified when there are updates to the investment portfolio of Fir Tree Capital Management LP, based on Form 13F filings with the SEC.

Stay updated on Fir Tree Capital Management LP with notifications on news.